Susquehanna International Group
MIRM icon

Susquehanna International Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Susquehanna International Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Buy
24,317
+21,157
+670% +$1.99M ﹤0.01% 5904
2025
Q4 		$250K Sell
3,160
-20,446
-87% -$1.47M ﹤0.01% 10380
2025
Q3 		$1.73M Sell
23,606
-28,804
-55% -$1.83M ﹤0.01% 6101
2025
Q2 		$2.67M Sell
52,410
-4,195
-7% -$187K ﹤0.01% 5198
2025
Q1 		$2.55M Buy
56,605
+30,861
+120% +$1.45M ﹤0.01% 4997
2024
Q4 		$1.06M Buy
25,744
+10,151
+65% +$423K ﹤0.01% 6793
2024
Q3 		$608K Sell
15,593
-19,370
-55% -$773K ﹤0.01% 7991
2024
Q2 		$1.2M Buy
34,963
+10,608
+44% +$278K ﹤0.01% 6162
2024
Q1 		$612K Buy
24,355
+16
+0.1% +$440 ﹤0.01% 8028
2023
Q4 		$718K Sell
24,339
-8,514
-26% -$258K ﹤0.01% 7791
2023
Q3 		$1.04M Buy
32,853
+15,987
+95% +$438K ﹤0.01% 6550
2023
Q2 		$436K Sell
16,866
-51,881
-75% -$1.38M ﹤0.01% 8627
2023
Q1 		$1.65M Buy
68,747
+47,900
+230% +$1.09M ﹤0.01% 5561
2022
Q4 		$407K Sell
20,847
-5,994
-22% -$118K ﹤0.01% 8359
2022
Q3 		$564K Sell
26,841
-1,102
-4% -$26.5K ﹤0.01% 8170
2022
Q2 		$544K Buy
27,943
+3,336
+14% +$78.7K ﹤0.01% 8059
2022
Q1 		$542K Buy
24,607
+660
+3% +$13.5K ﹤0.01% 8767
2021
Q4 		$382K Sell
23,947
-63,451
-73% -$987K ﹤0.01% 9897
2021
Q3 		$1.74M Buy
87,398
+76,987
+739% +$1.25M ﹤0.01% 6148
2021
Q2 		$180K Sell
10,411
-2,942
-22% -$52.7K ﹤0.01% 11699
2021
Q1 		$265K Buy
+13,353
New +$256K ﹤0.01% 10857

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Susquehanna International Group's MIRM Position: Q1 2026 in Review

Susquehanna International Group increased its Mirum Pharmaceuticals (MIRM) stake by 670% in Q1 2026, buying an estimated $1.99M and bringing the position to 24,317 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #5904.

Susquehanna International Group first reported a position in MIRM in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.67M in Q2 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Susquehanna International Group held 24,317 shares of Mirum Pharmaceuticals worth $2.25M as of Q1 2026.
  • Susquehanna International Group bought 21,157 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.99M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5904 holding.
  • Susquehanna International Group first reported a position in Mirum Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Susquehanna International Group's Mirum Pharmaceuticals position peaked at $2.67M in Q2 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.